Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
138 studies found for:    "Hemophilia B"
Show Display Options
Rank Status Study
1 Active, not recruiting Hemophilia B Gene Therapy - Spark
Condition: Hemophilia B
Intervention: Biological: AAV8-hFIX19
2 Recruiting A Gene Therapy Study for Hemophilia B
Condition: Hemophilia B
Intervention: Genetic: SPK-9001
3 Active, not recruiting LTFU for Gene Transfer Subjects With Hemophilia B
Condition: Hemophilia B
Intervention:
4 Recruiting Dose-Escalation Study Of A Self Complementary Adeno-Associated Viral Vector For Gene Transfer in Hemophilia B
Condition: Hemophilia B
Intervention: Genetic: Gene Transfer
5 Completed Study Evaluating BENEFIX in Previously Treated Patients With Hemophilia B
Condition: Hemophilia B
Intervention: Drug: Recombinant Factor IX Coagulation
6 Completed
Has Results
Post Marketing Surveillance To Observe Safety and Efficacy Of BeneFIX In Patients With Hemophilia B
Condition: Hemophilia B
Intervention: Drug: BeneFIX (coagulation factor IX (recombinant))
7 Completed Post Marketing Study in Haemophilia B Patients Using Nonafact® (Human Coagulation Factor IX)
Condition: Hemophilia B
Intervention: Drug: human coagulation Factor IX
8 Terminated Safety of a New Type of Treatment Called Gene Transfer for the Treatment of Severe Hemophilia B
Condition: Hemophilia B
Intervention: Genetic: Adeno-Associated Viral with Human Factor IX
9 Active, not recruiting Open-Label Single Ascending Dose of Adeno-associated Virus Serotype 8 Factor IX Gene Therapy in Adults With Hemophilia B
Condition: Hemophilia B
Intervention: Biological: AskBio009
10 Completed
Has Results
Study Comparing On-Demand Treatment With Two Prophylaxis Regimens Of BeneFIX In Patients With Severe Hemophilia B
Condition: Hemophilia B
Intervention: Drug: Recombinant Coagulation Factor IX (BeneFIX)
11 Completed
Has Results
Study To Compare On-Demand Treatment To A Prophylaxis Regimen Of BeneFIX In Subjects With Moderately Severe to Severe Hemophilia B
Condition: Hemophilia B
Intervention: Biological: Nonacog alfa
12 Completed Study Evaluating rFIX; BeneFIX in Severe Hemophilia B
Condition: Hemophilia B
Intervention: Drug: BeneFIX
13 Completed Prospective Registry of European Hemophilia B Patients Receiving BeneFIX® for Usual Use
Condition: Hemophilia B
Intervention:
14 Completed Phase I/IIa Study of FIXFc in Hemophilia B Patients
Condition: Hemophilia B
Intervention: Drug: rFIXFc
15 Completed Study to Describe the Allergic Reactions to Factor IX in Patients With Hemophilia B
Conditions: Hemophilia B;   Allergic Reactions
Intervention:
16 Withdrawn Study of Recombinant Factor IX Product, IB1001, in Previously Treated Subjects With Hemophilia B
Condition: Hemophilia B
Intervention: Biological: IB1001
17 Completed Study Evaluating Allergic Reactions To Benefix In Hemophilia B Patients
Condition: Hemophilia B
Interventions: Drug: blood draw;   Procedure: Blood draw
18 Recruiting Safety and Dose Finding Study of DTX101 (AAVrh10FIX) in Adults With Moderate/Severe to Severe Hemophilia B
Condition: Hemophilia B
Intervention: Genetic: AAVrh10FIX
19 Recruiting Trial of AAV5-hFIX in Severe or Moderately Severe Hemophilia B
Condition: Hemophilia B
Intervention: Genetic: AAV5-hFIX
20 Active, not recruiting Long-Term Safety and Efficacy of rFIXFc in the Prevention and Treatment of Bleeding Episodes in Previously Treated Participants With Hemophilia B
Condition: Severe Hemophilia B
Intervention: Biological: rFIXFc

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years